Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00837668 · ClinicalTrials.gov registry record
Stromal Gene Expression During Pulmonary Sarcoidosis
A clinical trial, sponsored by Ohio State University.
- Terminated
- Registry status
- 110
- Enrollment target
NCT00837668 is a clinical trial that was terminated before completion, run by Ohio State University. The registered enrollment target is 110 participants.
The verdict
NCT00837668 was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- 110 participants
- Enrollment target
Study Summary
to determine the genetic pathways operating at the tissue level to cause granulomatous inflammation in the lungs and lymph nodes of patients with sarcoidosis. By so doing, we hope to identify unique genetic mechanisms which will aid in the diagnosis of sarcoidosis and will help us understand the pathogenesis of this poorly understood disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2005-04 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00837668
The ClinicalTrials.gov registry entry for NCT00837668 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00837668 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00837668 about?
NCT00837668 is a clinical study titled "Stromal Gene Expression During Pulmonary Sarcoidosis". to determine the genetic pathways operating at the tissue level to cause granulomatous inflammation in the lungs and lymph nodes of patients with sarcoidosis. By so doing, we hope to identify unique genetic mechanisms which will aid in the diagnosis of sarcoidosis and will help us understand the pat...
What is the current status of trial NCT00837668?
This trial is currently terminated. The enrollment target is 110 participants. The study started on 2005-04. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT00837668?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.